Nutraceuticals in the Treatment of Pulmonary Arterial Hypertension

Int J Mol Sci. 2020 Jul 8;21(14):4827. doi: 10.3390/ijms21144827.

Abstract

Pulmonary arterial hypertension (PAH) is a severe disease characterized by the loss and obstructive remodeling of the pulmonary arterial wall, causing a rise in pulmonary arterial pressure and pulmonary vascular resistance, which is responsible for right heart failure, functional decline, and death. Although many drugs are available for the treatment of this condition, it continues to be life-threatening, and its long-term treatment is expensive. On the other hand, many natural compounds present in food have beneficial effects on several cardiovascular conditions. Several studies have explored many of the potential beneficial effects of natural plant products on PAH. However, the mechanisms by which natural products, such as nutraceuticals, exert protective and therapeutic effects on PAH are not fully understood. In this review, we analyze the current knowledge on nutraceuticals and their potential use in the protection and treatment of PAH, as well as whether nutraceuticals could enhance the effects of drugs used in PAH through similar mechanisms.

Keywords: anti-inflammatory; antihypertensive; antioxidant; antiproliferative; nutraceuticals; pulmonary arterial hypertension.

Publication types

  • Review

MeSH terms

  • Animals
  • Biological Products / pharmacology*
  • Biological Products / therapeutic use*
  • Dietary Supplements
  • Heart Failure / drug therapy
  • Humans
  • Pulmonary Arterial Hypertension / drug therapy*
  • Pulmonary Artery / drug effects

Substances

  • Biological Products